ArticleScientific reports2025
The association between urinary caffeine and caffeine metabolites and diabetic retinopathy in individuals with diabetes: NHANES 2009-2014.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Five-year systemic complications in diabetic retinopathy with integrated optical coherence tomography angiography and glycated hemoglobin.Frontiers in medicine · 2026Article
- Multi-omics integrated analysis identifies causal risk factors and therapeutic targets for diabetic retinopathy.Journal of translational medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The association between caffeine and diabetic retinopathy (DR) risk remains controversial. This study aims to examine the association between urinary caffeine and caffeine metabolites and self-reported DR risk in US individuals with diabetes. This cross-sectional study enrolled 535 participants with diabetes from the National Health and Nutrition Examination Survey (NHANES) 2009-2014. The high-performance liquid chromatography-electrospray ionization-tandem quadrupole mass spectrometry (HPLC-ESI-MS/MS) and internal standards labeled with stable isotopes were used to measure urinary caffeine and fourteen of its metabolites. Urinary caffeine and its metabolites levels were calibrated with urine creatinine for analysis. Caffeine and its metabolites were analyzed as continuous variables and categorical variables (≤ 50% or > 50%). Weighted logistic regression models were used to calculate odds ratios (OR) and 95% confidence intervals (CI). Subgroup analysis by sex was conducted. After adjusting for age, sex, race, BMI, smoking, alcohol drinking, duration of diabetes, glycated hemoglobin, hypertension, and total energy intake, ln-transformed 1-methyluric acid (1-MU) (OR = 1.27, 95% CI, 1.05 to 1.56, P = 0.016) and 5-acetylamino-6-amino-3-methyluracil (AAMU) (OR = 1.16, 95% CI, 1.01 to 1.34, P = 0.043) were associated with an increased DR risk. In median analysis, compared to lower levels (≤ 50%), higher levels (> 50%) of 1,7-dimethyluric acid (1,7-DMU) (OR = 1.92, 95% CI, 1.20 to 3.09, P = 0.008), caffeine (OR = 2.00, 95% CI, 1.27 to 3.16, P = 0.004), and AAMU (OR = 1.48, 95% CI, 1.04 to 2.10, P = 0.029) were associated with an increased DR risk. Sex-based analysis showed that ln-transformed 1-MU (OR = 1.48, 95% CI, 1.10 to 1.98, P = 0.012), 1,3,7-TMU (OR = 1.24, 95% CI, 1.04 to 1.49, P = 0.018) and caffeine (OR = 1.29, 95% CI, 1.03 to 1.60, P = 0.028) were associated with an increased DR risk in males. Compared to lower levels (≤ 50%), higher levels (> 50%) of 1,7-DMU (OR = 2.75, 95% CI, 1.33 to 5.70, P = 0.008), 1,3,7-TMU (OR = 2.26, 95% CI, 1.02 to 5.01, P = 0.044), caffeine (OR = 3.23, 95% CI, 1.53 to 6.82, P = 0.003), and AAMU (OR = 2.93, 95% CI, 1.16 to 7.40, P = 0.024) were associated with an increased DR risk in males. This study indicated that high urinary levels of 1-MU, 1,7-DMU, 1,3,7-TMU, caffeine and AAMU were associated with an increased risk of DR in US males with DM. Prospective studies are needed to verify these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.